TARS vs GILD: Which Stock is Better?
Side-by-side comparison of Tarsus Pharmaceuticals Inc and Gilead Sciences Inc in 2026
TARS
Tarsus Pharmaceuticals Inc
—
GILD
Gilead Sciences Inc
$134.77
Key Metrics Comparison
| Metric | TARS | GILD | Winner |
|---|---|---|---|
| Market Cap | $2.66B | $160.15B | GILD |
| P/E Ratio | N/A | 17.55 | GILD |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze TARS
Full quant analysis
Analyze GILD
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is TARS or GILD a better investment?
Comparing TARS and GILD: Tarsus Pharmaceuticals Inc has a market cap of $2.66B while Gilead Sciences Inc has $160.15B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between TARS and GILD?
TARS (Tarsus Pharmaceuticals Inc) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: TARS or GILD?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: TARS or GILD?
Both TARS and GILD show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: TARS or GILD?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: TARS or GILD?
Gilead Sciences Inc (GILD) is larger with a market cap of $160.15B compared to $2.66B for TARS.
Should I buy TARS or GILD in 2026?
Both TARS and GILD have investment merit. TARS trades at $N/A while GILD trades at $134.77. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between TARS and GILD stock?
Key differences: Market Cap ($2.66B vs $160.15B), P/E Ratio (N/A vs 17.5x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy TARS or GILD in 2026?
The choice between TARS and GILD depends on your investment goals. GILD shows higher revenue growth (0.0%). GILD has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between TARS and GILD?
TARS (Tarsus Pharmaceuticals Inc) has a market cap of $2.66B, while GILD (Gilead Sciences Inc) has a market cap of $160.15B. GILD is the larger company by market value.